Elmar J. Schnee is a Swiss businessperson who has been at the head of 12 different companies. Presently, Dr. Schnee occupies the position of Non-Executive Chairman for Moleac Pte Ltd., Chairman of Santhera Pharmaceuticals Holding AG, Chairman at Calliditas Therapeutics AB, Chairman at Noorik Biopharmaceuticals AG, Independent Non-Executive Chairman of Clinigen Group Plc and Chairman of Procom RX.

He is also on the board of 7 other companies.

In his past career Dr. Schnee held the position of Non-Executive Director at Cardiorentis AG, Non-Executive Chairman at Advanz Pharma Corp. Ltd., Chairman for Genkyotex SA, Managing Director at Caljem GmbH, Member-Executive Board & General Partner at Merck KGaA President & Chief Executive Officer of Merck Serono SA and Managing Director at Merck Santé SAS (both are subsidiaries of Merck KGaA), Managing Director at Sanofi-Synthélabo Ltd., Managing Director at Fisons Plc, Managing Director at Migliara Kaplan & Associates and Managing Director at UCB Pharma Ltd.

Dr. Schnee received an undergraduate degree and a graduate degree from Schweizerisches Institut für Betriebsökonomie AG.